Additionally, the Phase 1 clinical trial evaluating QTX3034, an oral G12D-preferring multi-KRAS inhibitor, as a monotherapy and in combination with cetuximab, continues to enroll patients, and data is ...
As more products begin to depend on battery-based energy storage systems, shifting away from metal-based solutions will be critical to facilitating the green energy transition. Now, a team has ...
A recent study highlights a groundbreaking development in foldable molecular paths within solid-state frameworks, illuminating their potential for dynamic pore control and transformative applications ...